New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic ReviewAlexia Alexandraki, Anastasia Constantinidou, Andri Papakonstantinou et al.|Cancers|2023Cited by 17
What is the role of QTc prolongation assessment in new drugs development phase I oncology trials?Giuseppe Curigliano, Filippo de Braud, Carlo M. Cipolla et al.|Journal of Clinical Oncology|2006Cited by 5